Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chang Ryul Park

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Translational Cancer Research|November 17, 2022
Mass size is a major predictor of hypertensive attack during surgery in patients with paraganglioma of retroperitoneumJi Hyung Yoon, Chang Ryul Park, Myeong Chan Park, et al.
Oncology Letters|July 3, 2018
<i>PCDHGA12</i> methylation biomarker in bronchial washing specimens as an adjunctive diagnostic tool to bronchoscopy in lung cancerIn Beom Jeong, Yoo Sang Yoon, Shin Young Park, et al.
Non-Coding RNA Research|March 23, 2023
Regulating POLR3G by MicroRNA-26a-5p as a promising therapeutic target of lung cancer stemness and chemosensitivityChang Ryul Park, Minhyeok Lee, Su Yel Lee, et al.
Lung Cancer (Amsterdam, Netherlands)|December 24, 2011
Prospective phase II trial of a combination of gemcitabine and UFT as first-line treatment in elderly patients with advanced non-small cell lung cancerJin Ho Baek, Hawk Kim, Jong-Joon Ahn, et al.
Lung Cancer (Amsterdam, Netherlands)|November 17, 2007
Prospective phase II trial of a combination of fixed dose rate infusion of gemcitabine with cisplatin and UFT as a first-line treatment in patients with advanced non-small-cell lung carcinomaSu Jin Shin, Hawk Kim, Jin Ho Baek, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Translational Cancer Research|November 17, 2022
Mass size is a major predictor of hypertensive attack during surgery in patients with paraganglioma of retroperitoneumJi Hyung Yoon, Chang Ryul Park, Myeong Chan Park, et al.
Oncology Letters|July 3, 2018
<i>PCDHGA12</i> methylation biomarker in bronchial washing specimens as an adjunctive diagnostic tool to bronchoscopy in lung cancerIn Beom Jeong, Yoo Sang Yoon, Shin Young Park, et al.
Non-Coding RNA Research|March 23, 2023
Regulating POLR3G by MicroRNA-26a-5p as a promising therapeutic target of lung cancer stemness and chemosensitivityChang Ryul Park, Minhyeok Lee, Su Yel Lee, et al.
Lung Cancer (Amsterdam, Netherlands)|December 24, 2011
Prospective phase II trial of a combination of gemcitabine and UFT as first-line treatment in elderly patients with advanced non-small cell lung cancerJin Ho Baek, Hawk Kim, Jong-Joon Ahn, et al.
Lung Cancer (Amsterdam, Netherlands)|November 17, 2007
Prospective phase II trial of a combination of fixed dose rate infusion of gemcitabine with cisplatin and UFT as a first-line treatment in patients with advanced non-small-cell lung carcinomaSu Jin Shin, Hawk Kim, Jin Ho Baek, et al.
Pageof 3